UnitedHealth Group (UNH) Boasts Earnings and Price Momentum: Should You Buy?
HAt Zacks, we provide our members with many different opportunities to take full advantage of the stock market, as well as how to invest in a way that leads to long-term success.
The Zacks Premium Service, which provides daily Zacks Ranking and Zacks Industry Ranking updates; full access to the Zacks #1 ranking list; Equity Research Reports; and premium action screens like the ESP filter on gains make those goals more manageable. All of the features can help you identify which stocks to buy, which to sell, and which industries are trending today.
The service also includes the Focus List, which is a long-term portfolio of the best stocks that offer a winning and market-beating combination of growth and momentum qualities.
Breaking down Zacks focus list
Building an investment portfolio from scratch can be difficult, so if you could, wouldn’t you take a look at a curated list of the best stocks?
Enter Zacks focus list. It’s a portfolio of 50 stocks that are expected to beat the market over the next 12 months; each selected company serves as a foundation for long-term investors looking to build an individual portfolio.
What makes the Focus list even more useful is that each pick comes with a comprehensive Zacks analyst report, which explains the reasoning behind each stock’s pick and why we think it is. a good long-term choice.
The portfolio’s past performance only reinforces why investors should take it as a starting point. For 2020, the Focus List gained 13.85% on an annualized basis compared to the S&P 500 return of 9.38%. Cumulatively, the portfolio returned 2,519.23% while the S&P returned 854.95%. Returns are for the period from February 1, 1996 to March 31, 2021.
Focus List Methodology
When stocks are selected for the Focus list, it reflects our enduring reliance on the power of earnings estimate revisions.
Brokerage analysts are responsible for determining a company’s growth and profitability expectations, or earnings estimates. These analysts work with company management to assess all factors that may affect future earnings, such as interest rates, the economy, and sector and industry optimism.
What a company will earn down the road also needs to be considered, and that’s why earnings estimate revisions are so important.
When a stock receives upward revisions to earnings estimates, it will likely see even more positive changes going forward. For example, if an analyst raised their earnings outlook last month, they will likely do so again this month, and other analysts will follow suit.
Harnessing the power of earnings estimate revisions is where the Zacks Ranking comes in. The Zacks Ranking is a unique and proprietary stock rating model that uses changes to a company’s quarterly earnings expectations to help investors to build a winning portfolio.
Four main factors make up the Zacks rank: Accord, Magnitude, Upside Down, and Surprise. Each is given a raw score which is recalculated each night and compiled into the leaderboard, and with this data the stocks are then ranked into five groups, ranging from “Strong Buy” to “Strong Sell”.
The Focus list is made up of stocks hand-picked from a long list of companies ranked #1 (Strong Buy) or #2 (Buy), meaning each new addition benefits from a bullish consensus on earnings among analysts.
Since stock prices react to revisions, it can be very profitable to buy stocks with rising earnings estimates. By buying stocks from the targeted list, you are therefore likely entering companies that will have increased future earnings estimates, which could lead to price momentum.
Discussion List Spotlight: UnitedHealth Group (UNH)
UnitedHealth Group, Inc. provides a wide range of healthcare products and services, such as Health Maintenance Organizations (HMOs), Point-of-Service (POS) Plans, Preferred Provider Organizations (PPOs) and managed fee-for-service programs.
On June 22, 2015, UNH was added to the Focus listing at $120.33 per share. Shares have risen 315.37% to $499.81 since then, and the company is No. 2 (buy) on the Zacks ranking.
For fiscal 2022, one analyst revised their earnings estimate up in the past 60 days, and Zacks’ consensus estimate rose $0.01 to $21.76. The UNH shows an average surprise of 3.7%.
Additionally, analysts expect UNH’s earnings to rise 14.4% for the current fiscal year.
Reveal winning actions
Unlock all of our powerful research, tools and analytics, including Zacks #1 Rank List, Stock Research Reports, ESP Zacks Earnings Filter, Premium Filter and more, as part of Zacks Premium. You’ll quickly identify stocks to buy, hold and sell, and target today’s hottest industries, to help improve your portfolio’s performance. Get full access now >>
Click to get this free report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.